Trulieve Announces US$100 Million Private Placement of 10.5% Senior Secured Notes
Rhea-AI Summary
Trulieve (OTCQX: TCNNF) has received commitments for a US$100.0 million private placement of 10.5% Senior Secured Notes due December 17, 2030 to be issued at 100% of face value. Interest will be payable semi-annually and notes may be redeemed in whole or in part starting two years after issue.
The offering is on a best-efforts basis with Canaccord Genuity Corp. as sole agent and is expected to close on December 17, 2025, subject to customary conditions and CSE approval. Net proceeds are earmarked for capital expenditures and general corporate purposes. The notes will be privately offered to qualified institutional and accredited investors and will be listed on the CSE after the four-month Canadian hold period.
Positive
- Raises US$100.0 million in secured financing
- Notes issued at 100% of face value
- Interest fixed at 10.5% per annum
- Proceeds designated for capital expenditures and corporate use
Negative
- Annual cash interest burden of 10.5% on US$100.0M
- Notes are senior secured, potentially encumbering assets
- Debt matures on December 17, 2030, creating medium-term repayment obligation
News Market Reaction
On the day this news was published, TCNNF gained 4.55%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
While TCNNF was down 3.01% over the prior 24 hours, key peers like GTBIF (+2.4%), NIKA (+3.59%) and CURLF (+1.43%) were positive, pointing to a more stock-specific setup rather than a sector-wide move.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 08 | Debt financing | Neutral | +4.5% | Announced US$100M 10.5% senior secured notes due 2030 via private placement. |
| Dec 08 | Debt redemption | Positive | -5.6% | Completed redemption of all US$368M 8.0% senior secured notes due 2026. |
| Dec 03 | Regulatory update | Positive | -1.0% | Received conditional approval for a Texas medical cannabis Dispensing Organization license. |
| Nov 05 | Earnings update | Neutral | +2.3% | Reported Q3 2025 results with strong cash flow but a net loss and planned note redemption. |
| Nov 04 | Debt redemption | Positive | +2.3% | Announced notice of redemption for all US$368M 8.0% senior secured notes due 2026. |
Recent corporate and financing events often coincided with notable price moves, with several positive balance sheet actions followed by both gains and selloffs, indicating mixed but active reactions to capital structure news.
Over the last two months, Trulieve reported Q3 2025 revenue of $288 million with strong cash flow and cash of $458 million, alongside plans to redeem $368 million of 8.0% notes due 2026. It then issued a formal redemption notice and later completed the full US$368 million redemption. Regulatory progress continued with conditional approval for a Texas license. Today’s US$100 million 10.5% senior secured notes placement adds a new layer to this balance sheet transition.
Market Pulse Summary
This announcement details a US$100 million private placement of 10.5% Senior Secured Notes due on or about December 17, 2030, with proceeds earmarked for capital expenditures and general corporate purposes. It follows recent steps to redeem US$368 million of 8.0% notes, signaling an ongoing balance sheet transition. Investors may track closing conditions, CSE listing after the four‑month hold, and how the higher coupon interacts with cash flow and leverage trends.
Key Terms
private placement financial
senior secured notes financial
qualified institutional buyers regulatory
accredited investors regulatory
Rule 144A regulatory
Regulation D regulatory
Regulation S regulatory
AI-generated analysis. Not financial advice.
The Offering is being conducted on a "best-efforts" basis pursuant to the terms of an agency agreement, between the Company and Canaccord Genuity Corp., as sole agent and sole bookrunner, and is expected to close on December 17, 2025, subject to customary closing conditions, including approval of the Canadian Securities Exchange (the "CSE"). The Company intends to make the required filings to list the Notes to be issued pursuant to the Offering on the CSE following the expiry of the four-month Canadian statutory hold period.
The Company intends to use the net proceeds of the Offering for capital expenditures and other general corporate purposes.
The offering and sale of the Notes have not been and will not be registered under the Securities Act of 1933, as amended (the "Securities Act"), or the laws of any other jurisdiction, and the Notes are being offered only (1) to persons reasonably believed to be qualified institutional buyers (as defined in Rule 144A) or to accredited investors (as defined in Rule 501 of Regulation D) in reliance on exemptions from the registration requirements under the Securities Act pursuant to Rule 506(b) of Regulation D and/or pursuant to Section 4(a)(2) of the Securities Act and similar exemptions under applicable
Forward-Looking Statements
This news release includes forward-looking information and statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to the Company's expectations or forecasts other plans, intentions, expectations, estimates, and beliefs and include statements regarding the completion of the Offering, the proposed use of the net proceeds of the Offering, the listing of the Notes on the CSE and other matters. Words such as "expects", "continue", "will", "anticipates" and "intends" or similar expressions are intended to identify forward-looking statements. These forward-looking statements are based on the Company's current projections and expectations about future events and trends that management believes might affect its financial condition, results of operations, business strategy and financial needs, and on certain assumptions and analysis made by the Company in light of the experience and perception of historical trends, current conditions and expected future developments and other factors management believes are appropriate. Forward-looking information and statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking information and statements herein, including, without limitation, the risks discussed under the heading "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2024 and in our periodic reports subsequently filed with the United States Securities and Exchange Commission and in the Company's filings on SEDAR+ at www.sedarplus.ca. There can be no assurance that any forward-looking information and statements herein will prove to be accurate, and accordingly readers are advised to rely on their own evaluation of such risks and uncertainties and should not place undue reliance upon such forward-looking information and statements. Any forward-looking information and statements herein are made as of the date hereof and, except as required by applicable laws, the Company assumes no obligation and disclaims any intention to update or revise any forward-looking information and statements herein or to update the reasons that actual events or results could or do differ from those projected in any forward looking information and statements herein, whether as a result of new information, future events or results, or otherwise.
About Trulieve
Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the
Facebook: @Trulieve
Instagram: @Trulieve
X: @Trulieve
Investor and Media Contact
Christine Hersey, Vice President of Investor Relations
+1 (424) 202-0210
Christine.Hersey@Trulieve.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/trulieve-announces-us100-million-private-placement-of-10-5-senior-secured-notes-302635857.html
SOURCE Trulieve Cannabis Corp.